Andersson K, Eneroth P
Neuroendocrinology. 1985 May;40(5):398-408. doi: 10.1159/000124105.
Using catecholamine (CA) fluorescence histochemistry in combination with quantitative microfluorimetry, it has been shown that chronic treatment with triiodothyronine (T3) and thyroxine (T4; 2 X 10 and 2 X 36 micrograms/kg i.p., respectively, twice daily for 10 days), but not acute treatment (1 and 3.6 mg/kg i.p., respectively, 2 h before killing), increases CA utilization in the medial and lateral palisade zones of the median eminence and reduces noradrenaline (NA) utilization in the parvocellular part and magnocellular part of the paraventricular hypothalamic nucleus of the hypophysectomized male rat. Following chronic T4 treatment it could also be shown that the CA levels in the medial and lateral palisade zones of the median eminence were increased, while the NA levels were reduced in the parvocellular part of the paraventricular hypothalamic nucleus. Chronic T3 treatment induced similar changes - increased CA levels in the medial palisade zone and reduced NA levels in the magnocellular part of the paraventricular hypothalamic nucleus. Within the telencephalon, chronic but not acute treatment with T3 or T4 selectively increased dopamine (DA) utilization within the diffuse type of DA nerve terminal systems of the nucleus accumbens. This action of chronic treatment of T3 or T4 was highly selective and no changes in DA levels could be demonstrated in any DA nerve terminals analyzed in the nucleus caudatus putamen; nucleus accumbens and tuberculum olfactorium. In all the experiments the TSH levels remained undetectable and the low basal serum prolactin levels were not modulated in any experimental group in spite of the treatment with a tyrosine hydroxylase inhibitor in the CA utilization experiments. Following 2-3 weeks after hypophysectomy, serum T3 and T4 were decreased by 30-50%. In the acute experiments with T3 or T4, serum T3 levels and T3 as well as T4 levels were markedly elevated after the respective treatments. In the chronic experiments, the T4 treatment resulted in significant increases in the serum levels of both T3 and T4. The present results indicate that discrete DA and NA nerve terminal systems within the median eminence (DA), nucleus accumbens (DA) and paraventricular hypothalamic nucleus (NA) can slowly respond to chronic treatment with T3 or T4. This effect is the result of a direct action of the thyroid hormones on the brain since TSH is absent in the hypophysectomized rat.(ABSTRACT TRUNCATED AT 400 WORDS)
运用儿茶酚胺(CA)荧光组织化学法结合定量显微荧光测定法,研究发现,对垂体切除的雄性大鼠进行三碘甲状腺原氨酸(T3)和甲状腺素(T4;分别为2×10和2×36微克/千克腹腔注射,每日两次,共10天)的慢性治疗,而非急性治疗(分别在处死前2小时腹腔注射1和3.6毫克/千克),会增加正中隆起内侧和外侧栅栏区的CA利用,并降低室旁下丘脑核小细胞部和大细胞部的去甲肾上腺素(NA)利用。慢性T4治疗后还发现,正中隆起内侧和外侧栅栏区的CA水平升高,而室旁下丘脑核小细胞部的NA水平降低。慢性T3治疗也引发了类似变化——正中隆起内侧栅栏区的CA水平升高,室旁下丘脑核大细胞部的NA水平降低。在端脑内,T3或T4的慢性而非急性治疗选择性地增加了伏隔核弥散型DA神经末梢系统内的多巴胺(DA)利用。T3或T4慢性治疗的这一作用具有高度选择性,在尾壳核、伏隔核和嗅结节分析的任何DA神经末梢中均未发现DA水平有变化。在所有实验中,促甲状腺激素(TSH)水平均未检测到,尽管在CA利用实验中使用了酪氨酸羟化酶抑制剂,但任何实验组的基础血清催乳素水平均未受到调节。垂体切除2 - 3周后,血清T3和T4降低了30 - 50%。在T3或T4的急性实验中,相应治疗后血清T3水平以及T3和T4水平均显著升高。在慢性实验中,T4治疗导致血清T3和T4水平显著升高。目前的结果表明,正中隆起(DA)、伏隔核(DA)和室旁下丘脑核(NA)内离散的DA和NA神经末梢系统可对T3或T4的慢性治疗产生缓慢反应。由于垂体切除的大鼠体内不存在TSH,这种效应是甲状腺激素对大脑直接作用的结果。(摘要截选至400字)